| Course | NR 586NP Population Health and Epidemiology for Advanced Nursing Practice |
|---|---|
| Week | 7 |
| Paper type | Population intervention plan |
| Length | About 1,160 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN, nurse practitioner core |
| Updated | October 2026 |
Free sample paper for NR 586NP Week 7
Population Intervention Plan: Same-Week Treatment Starts for Hepatitis C at a Rural Health Center, From a 48% Baseline to 70% Within Six Months by the End of 2027
Student Name
College of Nursing, Chamberlain University
NR 586NP: Population Health and Epidemiology for Advanced Nursing Practice
Instructor Name
Month Day, Year
Population Intervention Plan: Same-Week Treatment Starts for Hepatitis C at a Rural Health Center, From a 48% Baseline to 70% Within Six Months by the End of 2027
The Population and the Baseline
The population is adults whose blood showed active virus on an RNA test done by the county's health center. In 2025 there were 128. Of them, 61 (47.7%) started treatment within six months. For Medicaid patients the figure was 42.7%; for privately insured patients, 70.8%.
The Intervention
When an RNA result comes back positive, the health center's record will automatically schedule a visit with a nurse practitioner within seven days and place a standing order for the few pretreatment tests needed, drawn from the original sample where possible. At that visit, the nurse practitioner prescribes treatment using a simplified approach suitable for patients without cirrhosis, and a pharmacy technician employed by the health center submits the Medicaid prior authorization the same day, using a blood-based fibrosis score rather than a liver scan. The pharmacy technician tracks each request until the prescription is filled and calls the patient if it is not picked up within three days.
Choosing the Level, and Defending It
The intervention works at the level of delivery: a changed default (the automatic visit), a standing order and a staff role, rather than education. The disparity analysis placed the loss after diagnosis, at the nurse practitioner visit and the authorization wait, not in what patients know. Educating patients about hepatitis C would reach those already engaged and leave the process unchanged.
Nurse practitioners can safely treat most patients. In a trial in community health centers, nurse practitioners, primary care physicians and specialists achieved similar cure rates with direct-acting antivirals (Kattakuzhy et al., 2017). A simplified approach is appropriate for most patients without cirrhosis, which removes the need for the hospital visit that delays Medicaid patients.
Reach, Estimated Out Loud
Of the 128 patients with current infection in 2025, 27 never saw a nurse practitioner after the result. The automatic visit and a phone call within two days are aimed at them; if half are reached, that adds about 13 patients to the visit step. Of the 101 who were seen, 40 did not start treatment within six months; the same-day prior authorization and tracking are aimed at them. If two thirds of those delays were caused by the authorization step and are removed, that adds about 27 patients.
Combining these estimates: 61 + 13 + 27 = 101 of 128 would be about 79%. The estimate assumes everything works, which it will not. I have set the target below it.
The Target
Treatment started within six months for at least 70% of patients diagnosed in 2027, up from 47.7% in 2025, with the Medicaid rate at least 60%.
The People It Will Not Touch
This plan reaches only patients diagnosed at the health center. It does not reach county residents who are never tested, those tested elsewhere or those in jail. Using the national estimate of about 1% (Hofmeister et al., 2019) as a floor, and the health center's 3% among screened adults as an upper guide, somewhere between about 290 and 870 county adults may have current infection, while the health center diagnosed 128 in a year. Most infected residents are outside the plan's reach.
Within the health center, the plan also helps least those with no phone, no stable address or no transport. Improving the process for everyone could widen the gap within Medicaid between those with and without a phone. The syringe services program is the route to those patients, and a separate plan with the program for testing and treatment on the van would be needed.
How the Change Would Be Seen
Indicator: share of patients with a positive RNA result who start treatment within six months, overall and for Medicaid patients.
Source: the health center's hepatitis C registry, which records the RNA result date and the first prescription fill date from pharmacy data.
Frequency: monthly, with a six-month lag for each month's diagnosed patients; a three-month version will be tracked as an early signal.
Process measures: share of positive RNA results with a nurse practitioner visit within seven days; median days from prescription to prior authorization approval for Medicaid patients.
Balancing measure: nurse practitioner appointment wait for other patients, which should not rise by more than two days.
Why Not Another Level
Three other levels were considered. A media campaign about hepatitis C would raise awareness among people who already use the health center but would not change the steps that lose patients. A policy change at the state level, removing prior authorization, would act on the largest barrier, but the health center cannot make it happen; it is the subject of a separate brief. Peer navigators at the syringe program would reach people the health center does not see, which is valuable, but would not fix the process for those already diagnosed. The plan chosen acts on what the health center controls, and leaves the others to be pursued alongside it.
Lessons From the National Picture
National data show that most insured adults diagnosed with hepatitis C do not start treatment within a year, with Medicaid patients least likely to do so (Thompson et al., 2022). The health center's 2025 figures are better than that national picture but still leave half of patients untreated, so the plan aims at a level that would place the center well above national averages.
Resources
Pharmacy technician: one part-time position, 20 hours a week, about $23,000 a year. The health center's 340B pharmacy program is expected to cover this.
Nurse practitioner time: about 60 more treatment visits a year, roughly three hours a week.
Record build: about 12 hours of the analyst's time for the automatic scheduling and standing order.
Who Owns Each Part
The health center's medical director approves the standing order. The nurse practitioner lead for hepatitis C owns the registry and the monthly review. The pharmacy technician owns each authorization from submission to pickup. The quality coordinator produces the monthly report. If any owner leaves, the medical director names a replacement within a month, so the plan does not stall with one person's departure.
Timeline
Record build and standing order approval by March 2027. Pharmacy technician hired by April 2027. First review of three-month starts in October 2027 for patients diagnosed from April. Full-year 2027 result available by July 2028.
Risks
The prior authorization process could change. The pharmacy technician could leave. Automatic visits could be scheduled for patients who have already been treated elsewhere, which the technician will check before each visit.
References
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology, 69(3), 1020-1031. https://doi.org/10.1002/hep.30297
Kattakuzhy, S., Gross, C., Emmanuel, B., Teferi, G., Jenkins, V., Silk, R., Akoth, E., Thomas, A., Ahmed, C., Espinosa, M., Price, A., Rosenthal, E., Tang, L., Wilson, E., Bentzen, S., Masur, H., & Kottilil, S. (2017). Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial. Annals of Internal Medicine, 167(5), 311-318. https://doi.org/10.7326/M17-0118
Thompson, W. W., Symum, H., Sandul, A., Gupta, N., Patel, P., Nelson, N., Mermin, J., & Wester, C. (2022). Vital signs: Hepatitis C treatment among insured adults: United States, 2019-2020. MMWR. Morbidity and Mortality Weekly Report, 71(32), 1011-1017. https://doi.org/10.15585/mmwr.mm7132e1
What the NR 586NP Week 7 assignment asks for
The Week 7 plan opens with a population and a baseline, both as numbers, because a target without a starting point cannot be judged. Specify the intervention at a level someone could carry out, and choose that level deliberately: a changed default, a standing order, an outreach route or a rule, rather than education for everyone. Estimate reach openly, since that estimate is the heart of the plan. Write the target as a change in a rate over a stated period. Name the indicator, its source and how often it is read. Most rubrics mark down education for everybody, a missing baseline, a target written as activity and reach never examined.
Inside the NR 586NP Week 7 example
The sample sets the population as 128 adults with current infection in 2025 and the baseline as 47.7% treated within six months. The intervention schedules a nurse practitioner visit within seven days automatically, uses a standing order for pretreatment tests and adds a pharmacy technician who submits the authorization the same day. The level is defended from the disparity analysis and a trial of nonspecialist treatment. Reach is estimated step by step to about 79%, and the target is set below it. Residents outside the health center are estimated and named. Rejected levels, national comparison, measures, resources, owners, timeline and risks follow. Margin notes show where the level, the reach estimate and the target each earn credit.
Where the points sit in the NR 586NP Week 7 rubric
The plan that loses most is education for everybody, and this one changes defaults and roles instead. A missing baseline removes any way to detect change, while this plan opens with 47.7% and the Medicaid figure. A target written as activity, such as sessions held, costs a row, and this target is a rate over a year. Reach left unexamined hides the people a plan cannot touch, so reach is estimated in steps and the unreached are counted. Naming how the plan could widen a gap within Medicaid earns credit for honesty. A measurement plan with source, frequency and a balancing measure completes the evaluation criterion.
Common NR 586NP Week 7 mistakes, and how to avoid them
Weak NR 586NP Week 7 plans propose patient education as the main intervention. Others give a target with no baseline. Many count leaflets or sessions instead of a rate. Reach is rarely estimated, so the people left out are never named. Few plans say who owns each part. Start with a baseline from your own data, choose the level of change your analysis points to and estimate reach one step at a time. Name who the plan will not reach. If your problem differs, share your baseline and the steps where people drop out, and we can shape a sample plan around those figures. Set the target below your best-case estimate.
Get a NR 586NP Week 7 example written to your instructions
Send the plan instructions, the rubric and the population you have selected, and a custom example plan is written to that population and returned inside 24-48h at no charge for the first one. Where your section publishes a required heading list, include it and the example follows that list exactly.
More NR 586NP papers and MSN samples
- NR 586NP Week 1: From Case to Population Post
- NR 586NP Week 2: Community Profile
- NR 586NP Week 3: Rate Calculation Write-Up
- NR 586NP Week 4: Surveillance Data Review
- NR 586NP Week 5: Screening Program Appraisal
- NR 586NP Week 6: Health Disparity Analysis
- NR 586NP Week 8: Policy Brief
- NR 507 Week 7: Mechanism Write-up
- NR 585NP Week 7: Practice Change Recommendation
- NR 509 Week 7: Comprehensive Exam Write-up
- NR 584NP Week 7: Test of Change Write-Up
NR 586NP Week 7 questions, answered
Why does reach matter more than effect size?
Because a modest effect delivered across most of a population moves the rate further than a large effect delivered to a handful. It is also where inequity enters. Routes depending on people arriving, reading, remembering or holding a working phone reach the already advantaged first, so a plan can raise the average while widening the distance inside the group.
Does the intervention need to be original?
No, and inventing something unheard of usually reads as weakness. Adapting an established approach to a named population, with the adaptation and the reason for it stated, is the stronger document. The graded skill is fit between population, level of action and delivery route, not novelty. Cite the source of the approach and say what you altered for this group.
How specific does the target have to be?
Specific enough to be wrong. A named indicator, a starting figure, the amount of movement expected and the period over which it is expected, all inside one sentence. Vague improvement language protects the writer and costs points, because a plan that cannot fail cannot be assessed, and assessability is precisely what the requirement is testing.
Where can I find a free NR 586NP Week 7 sample paper?
The full population intervention plan for same-week hepatitis C treatment starts, with baseline, reach and target, is on this page.
Who does the NR 586NP Week 7 plan not reach?
County residents never tested, those tested elsewhere or in jail, likely several hundred adults, and within the center, patients without a phone, address or transport.